antibody

Documents about antibody

• Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid Tumors#859401ClinicalTrials.gov
• A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC#872699ClinicalTrials.gov
• EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)#872889ClinicalTrials.gov
• A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52 Antibody) Therapy in Newly Diagnosed Subjects With Type 1 Diabetes Mellitus#873975ClinicalTrials.gov
• Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer#880806ClinicalTrials.gov
• Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis#885073ClinicalTrials.gov
• Ivonescimab Combined With Chemotherapy for the Treatment of Leptomeningeal Metastases Failed to EGFR-TKIs#888241ClinicalTrials.gov
• A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma#893417ClinicalTrials.gov
• Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men#208256ClinicalTrials.gov
• HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis#230403ClinicalTrials.gov
• Selective Chemistry Enables Simultaneous ImmunoPET and Radioimmunotherapy with a Dual-Labeled Probe#307772Figshare
• Whole-Body Dynamic PET Imaging of Half-Life Extended Variable Domains of Heavy Chain-Only Antibodies: Beyond Blood Pharmacokinetics#370726HAL (France)
• Association of serum antibody to serotype-specific capsular (K), lipopolysaccharide (O) and MrkA with risk reduction of invasive <i>Klebsiella pneumoniae</i> disease in young infants: an observational study#451911Europe PMC
• Additional file 3 of Giardia duodenalis and Entamoeba spp.: Coprological and antibody–based approaches across farm animals in Egypt#456764Figshare
• Additional file 2 of Giardia duodenalis and Entamoeba spp.: Coprological and antibody–based approaches across farm animals in Egypt#456765Figshare
• Additional file 1 of Giardia duodenalis and Entamoeba spp.: Coprological and antibody–based approaches across farm animals in Egypt#456766Figshare
• Using Cyclic Immunofluorescence (CyCIF), Deep-learning, and Human Tumor Microarrays (hTMAs) for Antibody Validation and Creation of an Atlas of Cancers Emphasizing Unique Phenotypes#643572Harvard DASH
• Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations#644234IRIS
• Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid Tumors#826193ClinicalTrials.gov
• Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination#839157ClinicalTrials.gov
• Evaluation of the Sensitivity of Endoscopy to Detect Nasopharyngeal Carcinoma (NPC) in an Epstein-Barr Virus (EBV)-Based NPC Screening Project in China#842312ClinicalTrials.gov
• A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor C-Met, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors#851200ClinicalTrials.gov
• Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year#855805ClinicalTrials.gov
• Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)#856391ClinicalTrials.gov
• A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid Tumors#861343ClinicalTrials.gov
• Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines#865383ClinicalTrials.gov
• A Multiple Dose Escalation Study of ASKP1240 in Subjects With Moderate to Severe Plaque Psoriasis#869703ClinicalTrials.gov
• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants#870271ClinicalTrials.gov
• S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery#874419ClinicalTrials.gov
• A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer#882413ClinicalTrials.gov
• Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in mice#139718HAL (France)
• Clinical Utility of SARS-CoV-2 Antibody Titers in the Management of Patients With Long COVID Infected With the Omicron Variant#194799OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Decreased expression of Ly-1 antibody reactive clone (Lyar) triggers enhanced adipogenesis of bone marrow mesenchymal stromal cells in aged bone marrow#232911PLOS
• Enhancing the efficacy of B7-H3-targeting antibody-drug conjugate DS-7300a in TP53-deficient tumors by inducing ferroptosis#626794Springer Nature OA
• First in Human Study of AZD9592 in Solid Tumors#803531ClinicalTrials.gov
• A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN#837251ClinicalTrials.gov
• Evaluation of Safety and Efficacy of Fludarabine, Cyclophosphamide, and Rituximab (FCR) +/- Lumiliximab in Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)#854576ClinicalTrials.gov
• A Study of MRG002 in the Treatment of Patients With HER2-expressed Advanced Malignant Solid Tumors.#859836ClinicalTrials.gov
• A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Anti-PD-1 Antibody (HLX10) in Combination With Avastin Biosimilar (HLX04) in Patients With Advanced Solid Tumors#866856ClinicalTrials.gov
• Efficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)#868009ClinicalTrials.gov
• Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH#870460ClinicalTrials.gov
• A Study to Assess the Effect of Avacopan at Therapeutic and Supratherapeutic Doses on the QT/QTc Interval in Healthy Participants#873743ClinicalTrials.gov
• Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis#883940ClinicalTrials.gov
• Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients#893031ClinicalTrials.gov
• Cross-protection against highly pathogenic avian influenza H5N1 virus from seasonal influenza vaccines: a systematic review and meta-analysis of ferret studies#120189Europe PMC
• Oral adjuvanted Vibrio vaccine enhances antibody production and lysozyme activity in the serum and mucus of marine-cultured red hybrid tilapia (Oreochromis sp.) against V. harveyi and V. alginolyticus#201280Universiti Putra Malaysia Institutional Repository
• Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of Booster Doses of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received One or Four Doses of the Same Vaccine#356525ClinicalTrials.gov
• MolT5-Linker: A Transformer-Based Sequence- and Putative Site-Guided Generative Framework for Antibody-Drug Conjugate Linkers#382034Figshare
• Préparation, bioconjugaison et optimisation de nanomatériaux de MoOX pour la thérapie photothermique ciblée du cancer#395330HAL (France)
• Relaxation Processes in Freeze-Dried Monoclonal Antibody–Sucrose Formulations: The Role of Water Content#403921Figshare